Search Results - "Lobo, Jose M"

Biosimilar medicines used for cancer therapy in Europe: a review by Santos, Sofia B., Sousa Lobo, José M., Silva, Ana C.

“…•Several new biosimilar medicines are continuously been introduced in the market.•Current oncologic biosimilars are epoetins, filgrastim, and monoclonal…”
Get full text

Skin Depigmenting Agents in Anti-Aging Cosmetics: A Medicinal Perspective on Emerging Ingredients by Resende, Diana I. S. P., Ferreira, Marta S., Lobo, José M. S., Sousa, Emília, Almeida, Isabel F.

“…Human skin aging results from intrinsic and extrinsic factors. Uneven pigmentation is one of the major changes of extrinsic aging. Many compounds have been…”
Get full text

Nucleic Acids Delivery Systems: A Challenge for Pharmaceutical Technologists by Silva, Ana C, Lopes, Carla M, Sousa Lobo, Jose M, Amaral, M Helena

“…Nucleic acids (NA) therapies, including therapy with genes, aptamers or antisense oligonucleotides, have been showing promising results, especially in the…”
Get more information

UV Filters: Challenges and Prospects by Jesus, Ana, Sousa, Emília, Cruz, Maria T, Cidade, Honorina, Lobo, José M Sousa, Almeida, Isabel F

“…The use of sunscreens is an established and recommended practice to protect skin from solar-induced damage. Around 30 UV filters can be used in sunscreen…”
Get full text

Marine Ingredients for Sensitive Skin: Market Overview by Ferreira, Marta Salvador, Resende, Diana I S P, Lobo, José M Sousa, Sousa, Emília, Almeida, Isabel F

“…Marine ingredients are a source of new chemical entities with biological action, which is the reason why they have gained relevance in the cosmetic industry…”
Get full text

In Vitro Evaluation of the Photoreactivity and Phototoxicity of Natural Polyphenol Antioxidants by Aguiar, Brandon, Carmo, Helena, Garrido, Jorge, Sousa Lobo, José M, Almeida, Isabel F

“…Polyphenols are a large family of natural compounds widely used in cosmetic products due to their antioxidant and anti-inflammatory beneficial properties and…”
Get full text

BRAF mutation predicts sensitivity to MEK inhibition by Rosen, Neal, Solit, David B, Garraway, Levi A, Pratilas, Christine A, Sawai, Ayana, Getz, Gad, Basso, Andrea, Ye, Qing, Lobo, Jose M, She, Yuhong, Osman, Iman, Golub, Todd R, Sebolt-Leopold, Judith, Sellers, William R

“…The kinase pathway comprising RAS, RAF, mitogen-activated protein kinase kinase (MEK) and extracellular signal regulated kinase (ERK) is activated in most…”
Get full text

Sensitive skin: Active ingredients on the spotlight by Ferreira, Marta S., Sousa Lobo, José M., Almeida, Isabel F.

“…Objective Sensitive skin is characterized by self‐reported sensory perceptions in response to stimuli that should not provoke unpleasant sensations. Cosmetic…”
Get full text

Benefits of skin application of piceatannol—A minireview by Krambeck, Karolline, Santos, Delfim, Sousa Lobo, José M., Amaral, Maria Helena

“…The skin is the largest organ of the human body and has several functions such as barrier against external agents, the maintenance of temperature and…”
Get full text

Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis by Teixeira, Ana, Teixeira, Maribel, Almeida, Vera, Gaio, Rita, Torres, Tiago, Magina, Sofia, Cunha, Cátia, Sousa Lobo, José M, Almeida, Isabel F

“…The influence of the vehicle in topical treatment adherence remains to be elucidated. The aim of this study is to analyze the influence of the pharmaceutical…”
Get full text

Up-to-Date Overview of the Use of Natural Ingredients in Sunscreens by Resende, Diana I S P, Jesus, Ana, Sousa Lobo, José M, Sousa, Emília, Cruz, Maria T, Cidade, Honorina, Almeida, Isabel F

“…The photoprotective skincare segment is in high demand to meet consumer concerns on UV-induced skin damage, with a recent trend towards sunscreen alternatives…”
Get full text

Recent Trends on UV filters by Jesus, Ana, Augusto, Inês, Duarte, Joana, Sousa, Emília, Cidade, Honorina, Cruz, Maria T., Lobo, José M. Sousa, Almeida, Isabel F.

“…UV filters are the shield ingredients of sunscreens against the negative effects of solar radiation. Since the discovery of the first UV filter, nearly 30…”
Get full text

Lipid nanoparticles for the delivery of biopharmaceuticals by Silva, Ana C, Amaral, Maria H, Lobo, Jose M S, Lopes, Carla M

“…Biopharmaceuticals comprise therapeutic protein-based, nucleic acids and cell-based products. According to their therapeutic success, the clinical use of these…”
Get more information

Delivery systems for biopharmaceuticals. Part II: Liposomes, Micelles, Microemulsions and Dendrimers by Silva, Ana C, Lopes, Carla M, Lobo, José M S, Amaral, Maria H

“…Biopharmaceuticals are a generation of drugs that include peptides, proteins, nucleic acids and cell products. According to their particular molecular…”
Get more information

Delivery Systems for Biopharmaceuticals. Part I: Nanoparticles and Microparticles by Silva, Ana C, Lopes, Carla M, Lobo, José M S, Amaral, Maria H

“…Pharmaceutical biotechnology has been showing therapeutic success never achieved with conventional drug molecules. Therefore, biopharmaceutical products are…”
Get more information

Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen by Lopes, Carla Martins, Lobo, José M Sousa, Pinto, João F, Costa, Paulo C

“…The purpose of the present research was to produce a quick/slow biphasic delivery system for ibuprofen. A dual-component tablet made of a sustained release…”
Get full text

On the viability of five probiotic strains when immobilised on various polymers by RODRIGUES, DINA, ROCHA-SANTOS, TERESA, SOUSA, SÉRGIO, GOMES, ANA M, PINTADO, MARIA M, XAVIER MALCATA, F, SOUSA LOBO, JOSÉ M, SILVA, JOSÉ P, COSTA, PAULO, AMARAL, MARIA H, FREITAS, ANA C

“…The viability of probiotic bacteria in six food-grade polymers, at two concentrations, was evaluated in order to predict their feasibility as materials for…”
Get full text

Management of skin adverse reactions in oncology by Silva, Diva, Gomes, Ana, MS Lobo, José, Almeida, Vera, Almeida, Isabel F

“…Chemo and targeted anticancer therapies present significant skin adverse reactions, which impair the patients’ quality of life. Cutaneous toxicities lead to…”
Get full text

Abstract 4682: Membrane protein expression and activity following inhibition of B-cell receptor-initiated signaling by WBMP-4, a therapeutic antibody for leukemia/lymphoma by Welt, Rachel S., Kostyal, David, Raymond, Virginia, Lobo, Jose M., Welt, Sydney

“…Abstract The B-cell Receptor (BCR), comprising membrane Ig (mIg) and CD79a/b, controls normal signaling in B-cells, but dysregulation of this signaling is the…”
Get full text

Abstract P40: Therapeutic anti-B-cell Receptor antibody, WBMP-4, modulates malignant B-cell signaling and induces apoptosis by Welt, Rachel S, Kostyal, David, Lobo, Jose M, Raymond, Virginia, Welt, Sydney

“…Abstract The B-cell Receptor (BCR), comprising CD79a/b and membrane Ig, initiates a driver pathway of cell survival and proliferation, and is a rational drug…”
Get full text